In 1968, doctors told Greg Kindell that he had acute myeloid leukemia and he had just six weeks to live. Now he’s been cancer-free for 50 years.
diagnosis
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
New colon cancer finding could lead to earlier diagnosis—and better outcomes
The most common method of screening for colon cancer is a colonoscopy. However, certain cancer-causing polyps can be easily missed during an examination.